The miR-17-92 cluster is composed of seven miRNAs (microRNAs; miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a-1). Previous studies have indicated that this cluster is involved in cell proliferation and their overexpression has been seen in several types of cancer. We have assessed the overexpression effects of miR-17-92 on the expression of several genes associated with cell-cycle regulation. The human miR-17-92 gene was cloned into a transposone-based vector, piggyBac and transfected into HEK-293T [HEK-293 cells (human embryonic kidney cells) expressing the large T-antigen of SV40 (simian virus 40)] cell line. Gene expression analysis indicated that up-regulation of this cluster causes significant changes in the expression of several cell-cycle related genes, including CDK2 (cyclin-dependent kinase 2), cyclin-D2, c-Myc and CREB (cAMP-response-element-binding protein). Other methods of transcripts assessment confirmed miR-17-92 overexpression enhances cell proliferation.
Objective
Preeclampsia (PE) is a life‐threatening complication of pregnancy that accounts for 12% of all maternal deaths worldwide. The aim of this study is to investigate the relationships between the polymorphisms of angiotensinogen (AGT) gene and preeclampsia.
Material and methods
In this study, 240 unrelated preeclampsia patients and 178 normotensive women were examined. Genomic DNA was extracted then we assessed M235T(C/T) and A‐6G polymorphisms of the AGT gene. Genotyping of M235T and A‐6G polymorphisms were performed using SSP‐PCR and MS‐PCR, respectively.
Results
A significant protective association was observed between A‐6G G allele, A‐6G A/G heterozygote genotype (OR = 0.6, p = 0.007 and OR = 0.6, p = 0.04) against PE. Furthermore, it was shown that two copies of A‐6G A allele would increase PE risk (OR: 0.62, p = 0.04). Our results did not show a significant association for M235T polymorphism and PE. However, the combinations of A‐6G A/A genotype and M235T T/C genotype (OR = 0.4, p = 0.02) and also A‐6G A/G genotype and M235T T/C genotype (OR = 0.5, p = 0.04) in controls represented a significant protective association against PE.
Conclusion
According to the existence of significant correlation between two candidate polymorphisms, A‐6G and M235T polymorphisms, with PE disease in our study, they may be considered as valuable factors in susceptibility to PE disease in Iranian women.
In the present study, common carp (Cyprinus carpio) were fed with diet supplemented with 0% (M0) or 0.5% (M0.5) myrcene for 6 week and exposed to ambient copper (0.2 mg/L) for further 2 weeks. Gene expressions of superoxide dismutase (sod), catalase (cat), glutathione peroxidase (gpx), glutathione reductase (gr) and glutathione S‐transferase (gst) were assayed in the fish brain and kidney, and thiobarbituric reactive substance (TBARS) levels were determined in blood plasma. The results showed that there was no significant difference in TBARS levels between the M0 and M0.5 treatments, before the copper exposure; however, the M0 had significantly higher TBARS levels compared to the M0.5, after the copper exposure. The antioxidant genes showed different patterns in the fish brain and kidney. The genes were up‐regulated in the fish brain by dietary myrcene and copper exposure. However, in the fish kidney, the M0.5 treatment showed no change in sod, cat, gpx before and after the copper exposure. The results suggest that myrcene is capable to induce antioxidant enzymes that prepare the fish for a further oxidative condition (i.e. copper exposure). Dietary myrcene at 0.5% level is suggested for common carp before treatment with copper sulphate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.